Vaccines : Actualité Vaccines en direct - P2 | Bourse Reflex
Accueil > Tags > Vaccines

  • Toutes les actualités en rapport avec « Vaccines »

07/01 18:00 Vaccines - SUMMARY OF GENTICEL'S LIQUIDITY CONTRACT WITH ODDO CORPORATE FINANCE

07/01 07:30 Vaccines - GENTICEL TO EVALUATE ROCHE MOLECULAR SYSTEMS' COBAS(R) HPV TEST IN PREPARATION FOR PHASE 3 PROGRAM OF GTL001

05/01 19:00 Vaccines - Genticel appoints Rémi Palmantier, PhD, as Chief Scientific Officer to accelerate its development

10/12 18:15 Vaccines - Disclosure of the total number of voting rights and shares composing the share capital

02/12 18:00 Vaccines - Benedikt Timmerman resumes CEO position at Genticel

29/10 18:00 Vaccines - Genticel Announces First Patient Treated in U.S. Phase 1 Clinical Trial of GTL001, Company's Therapeutic Vaccine Candidate against HPV 16/18 Infections

28/10 18:45 Vaccines - Business Update - Third Quarter 2015

01/10 18:00 Vaccines - OCEASOFT PARTICIPATING IN COLD CHAIN GLOBAL CONFERENCE IN BOSTON, OCTOBER 5-9, 2015

28/09 18:00 Vaccines - Disclosure of the total number of voting rights and shares composing the share capital

21/09 17:40 Vaccines - Genticel presents first half 2015 financial results, operational progress and outlook

08/09 07:30 Vaccines - US patent granted for use of Genticel's antigen delivery vectors in combination therapy to treat cancer

01/09 18:00 Vaccines - GENTICEL to meet investors

28/07 18:00 Vaccines - Business Update - Second Quarter 2015

07/07 18:00 Vaccines - Independent Data Safety Monitoring Board Recommends Continuation per Protocol of Genticel's Phase 2 Clinical Trial of GTL001 (ProCervix), Company's First-in-class HPV Therapeutic Vaccine Candidate

03/07 18:00 Vaccines - Summary of Genticel's liquidity contract with Oddo Corporate Finance

02/07 18:15 Vaccines - Genticel CFO, Martin Koch, Appointed CEO to Replace Benedikt Timmerman during Temporary Medical Leave of Absence

16/06 07:00 Vaccines - Genticel Receives FDA Clearance of IND Application for U.S. Phase 1 Clinical Trial of GTL001 (ProCervix), Company's First-in-class HPV Therapeutic Vaccine Candidate

01/06 07:00 Vaccines - Genticel Announces Positive Preclinical Proof of Concept Results of GTL002, its New Multivalent HPV Therapeutic Vaccine Candidate Based on Company's Versatile Vaxiclase Platform

21/05 18:00 Vaccines - Documents Available for Annual General Meeting of Shareholders

28/04 19:00 Vaccines - Business Update - First Quarter 2015